CNTF: a target therapeutic for obesity-related metabolic disease?

Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte
Vance Matthews, Mark A Febbraio

Abstract

Obesity and type 2 diabetes are the most prevalent metabolic diseases in the western world. Alarmingly, the cluster of pathologies characteristic of obesity-induced disease have started to emerge in children, a phenomenon that up until a decade ago was inconceivable. Hence, the development of new strategies to treat 'metabolic disease' is most warranted. Growing evidence suggests that during type 2 diabetes, a state of chronic low-grade inflammation exists in metabolically active tissues such as the liver, adipose tissue and skeletal muscle. This inflammation is often secondary to lipid accumulation in insulin-responsive tissues. Recent studies have focused on the therapeutic potential of ciliary neurotrophic factor (CNTF). CNTF is a pluripotent neurocytokine and, has shown promise as a potential anti-obesogenic therapy. CNTF acts both centrally and peripherally, mimics the biological actions of leptin while overcoming "leptin resistance", remains effective even after termination of therapy if administered centrally, and appears to reduce inflammatory signaling cascades associated with lipid accumulation in liver and skeletal muscle. The advantages and disadvantages of CNTF as a therapeutic strategy to alleviate obesity-associa...Continue Reading

References

Jul 5, 1991·Science·S DavisG D Yancopoulos
Feb 1, 1996·The New England Journal of Medicine·R V ConsidineT L Bauer
Dec 29, 1995·Cell·L A TartagliaR I Tepper
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·I GloaguenR Laufer
Jun 26, 1997·Nature·R StarrD J Hilton
Jun 17, 1998·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·H MünzbergA Hamann
May 17, 2000·Pharmaceutica acta Helvetiae·M W SleemanS J Wiegand
Nov 4, 2000·Trends in Biotechnology·K J KallenS Rose-John
Mar 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·P D LambertS J Wiegand
Apr 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·S P Kalra
Jun 18, 2002·American Journal of Physiology. Endocrinology and Metabolism·Gregory R SteinbergDavid J Dyck
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Katherine M FlegalClifford L Johnson
Nov 9, 2002·The Journal of Biological Chemistry·Sanjin ZvonicJacqueline M Stephens
Nov 26, 2002·Nature·Jiro HirosumiGökhan S Hotamisligil
Jan 24, 2003·Diabetes·Kazuhisa MaedaGökhan S Hotamisligil
Apr 10, 2003·JAMA : the Journal of the American Medical Association·Mark P EttingerHans-Peter Guler
May 17, 2003·Science·Kitt Falk PetersenGerald I Shulman
Jul 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Mary Elizabeth PattiLawrence J Mandarino
Oct 28, 2003·Diabetes·Peter J KloverRobert A Mooney
Nov 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·M W SleemanS J Wiegand
Dec 13, 2003·Science·C G Nicholas Mascie-Taylor, Enamul Karim
Dec 31, 2003·Trends in Genetics : TIG·Matthias Ernst, Brendan J Jenkins
Feb 13, 2004·The New England Journal of Medicine·Kitt Falk PetersenGerald I Shulman
Jul 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kohjiro UekiC Ronald Kahn
Apr 22, 2005·Molecular Biology of the Cell·Xiaoping ChenMing Fan
Jun 16, 2005·Diabetes Research and Clinical Practice·Francesco GiorginoAnna Leonardini

❮ Previous
Next ❯

Citations

May 15, 2012·Journal of Molecular Neuroscience : MN·Samira FargaliStephen R Salton
Dec 3, 2008·Expert Opinion on Emerging Drugs·Gordon S Lynch
May 10, 2012·Drug Discovery Today·Aruni S Arachchige DonX F Steven Zheng
Dec 21, 2011·Progress in Retinal and Eye Research·Rong WenPaul A Sieving
Jan 17, 2012·Vascular Pharmacology·Svitlana DemyanetsJohann Wojta
Feb 2, 2011·Pediatric Clinics of North America·Donald E GreydanusCynthia Feucht
Mar 12, 2010·Journal of Psychiatric Research·Mònica GratacòsXavier Estivill
Apr 3, 2015·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Maria-Angeles Carrillo-de SauvageCarole Escartin
Nov 1, 2012·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·G Solinas
Mar 1, 2012·Orvosi hetilap·Gábor SimonyiJ Róbert Bedros
Dec 17, 2014·Metabolism: Clinical and Experimental·Neira SáinzJosé Alfredo Martínez
Jul 26, 2016·Frontiers in Neuroscience·Martina SenzacquaAntonio Giordano
Jan 23, 2016·The Journal of Experimental Biology·Lena CronMark A Febbraio
Mar 15, 2016·The FEBS Journal·Esteban N GurzovDaniel J Gough
Mar 21, 2009·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.